These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 27331625)

  • 1. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
    Miranda-Gonçalves V; Granja S; Martinho O; Honavar M; Pojo M; Costa BM; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Reis RM; Baltazar F
    Oncotarget; 2016 Jul; 7(29):46335-46353. PubMed ID: 27331625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets.
    Miranda-Gonçalves V; Honavar M; Pinheiro C; Martinho O; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Palmeirim I; Reis RM; Baltazar F
    Neuro Oncol; 2013 Feb; 15(2):172-88. PubMed ID: 23258846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lactate transport suppresses in vivo breast tumour growth.
    Morais-Santos F; Granja S; Miranda-Gonçalves V; Moreira AH; Queirós S; Vilaça JL; Schmitt FC; Longatto-Filho A; Paredes J; Baltazar F; Pinheiro C
    Oncotarget; 2015 Aug; 6(22):19177-89. PubMed ID: 26203664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk.
    Miranda-Gonçalves V; Bezerra F; Costa-Almeida R; Freitas-Cunha M; Soares R; Martinho O; Reis RM; Pinheiro C; Baltazar F
    Mol Carcinog; 2017 Dec; 56(12):2630-2642. PubMed ID: 28762551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers.
    Kubelt C; Peters S; Ahmeti H; Huhndorf M; Huber L; Cohrs G; Hövener JB; Jansen O; Synowitz M; Held-Feindt J
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma.
    Miranda-Gonçalves V; Gonçalves CS; Granja S; Vieira de Castro J; Reis RM; Costa BM; Baltazar F
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298681
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
    Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
    BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
    Wu DH; Liang H; Lu SN; Wang H; Su ZL; Zhang L; Ma JQ; Guo M; Tai S; Yu S
    Cell Physiol Biochem; 2018; 50(3):924-935. PubMed ID: 30355947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
    Afonso J; Pinto T; Simões-Sousa S; Schmitt F; Longatto-Filho A; Pinheiro C; Marques H; Baltazar F
    Cell Oncol (Dordr); 2019 Jun; 42(3):303-318. PubMed ID: 30790227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
    Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
    Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner.
    Lim KS; Lim KJ; Price AC; Orr BA; Eberhart CG; Bar EE
    Oncogene; 2014 Aug; 33(35):4433-41. PubMed ID: 24077291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
    Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells.
    Cheng C; Edin NF; Lauritzen KH; Aspmodal I; Christoffersen S; Jian L; Rasmussen LJ; Pettersen EO; Xiaoqun G; Bergersen LH
    Cell Oncol (Dordr); 2012 Jun; 35(3):217-27. PubMed ID: 22700320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters.
    Viswanath P; Najac C; Izquierdo-Garcia JL; Pankov A; Hong C; Eriksson P; Costello JF; Pieper RO; Ronen SM
    Oncotarget; 2016 Jun; 7(23):34942-55. PubMed ID: 27144334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
    Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
    Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle.
    Bonen A
    Eur J Appl Physiol; 2001 Nov; 86(1):6-11. PubMed ID: 11820324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure.
    Andersen S; Solstad Ø; Moi L; Donnem T; Eilertsen M; Nordby Y; Ness N; Richardsen E; Busund LT; Bremnes RM
    Urol Oncol; 2015 Aug; 33(8):338.e9-17. PubMed ID: 26066969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting lactate production and efflux in prostate cancer.
    Pereira-Nunes A; Simões-Sousa S; Pinheiro C; Miranda-Gonçalves V; Granja S; Baltazar F
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165894. PubMed ID: 32650130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.